F. M. Gore, P. Bloem, G. C. Patton, J. Ferguson, V. Joseph et al., Global burden of disease in young people aged 10-24 years: a systematic analysis, Lancet, vol.377, issue.9783, pp.2093-2102, 2011.

P. Y. Collins, V. Patel, S. S. Joestl, D. March, T. R. Insel et al., Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health, Nature, vol.475, issue.7354, pp.27-30, 2011.

L. H. Price and G. R. Heninger, Lithium in the treatment of mood disorders, N Engl J Med, vol.331, issue.9, pp.591-598, 1994.

M. Maj, R. Pirozzi, and L. Magliano, Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: prevalence and predictors, Am J Psychiatry, vol.152, issue.12, pp.1810-1811, 1995.

F. Bellivier, R. Belzeaux, J. Scott, P. Courtet, J. Golmard et al., Anticonvulsants and suicide attempts in bipolar I disorders, Acta Psychiatr Scand, vol.135, issue.5, pp.470-478, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01783781

G. S. Malhi and M. Tanious, Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations, CNS Drugs, vol.25, issue.4, pp.289-298, 2011.

L. N. Yatham, S. H. Kennedy, S. V. Parikh, A. Schaffer, S. Beaulieu et al., Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update, Bipolar Disord, vol.15, issue.1, pp.1-44, 2013.

D. P. Thornhill, Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage, Int J Clin Pharmacol Ther Toxicol, vol.24, issue.5, pp.257-261, 1986.

A. Amdisen, Serum level monitoring and clinical pharmacokinetics of lithium, Clin Pharmacokinet, vol.2, issue.2, pp.73-92, 1977.

T. B. Cooper, G. M. Simpson, J. H. Lee, and P. E. Bergner, Evaluation of a slow-release lithium carbonate formulation, Am J Psychiatry, vol.135, issue.8, pp.917-922, 1978.

B. Sproule, Lithium in bipolar disorder: can drug concentrations predict therapeutic effect?, Clin Pharmacokinet, vol.41, issue.9, pp.639-660, 2002.

, Résumé des Caractéristiques du Produit, p.2017

B. A. Sproule, B. G. Hardy, and K. I. Shulman, Differential pharmacokinetics of lithium in elderly patients, Drugs Aging, vol.16, issue.3, pp.165-177, 2000.

E. M. Grandjean and J. Aubry, Lithium: updated human knowledge using an evidence-based approach. Part II: clinical pharmacology and therapeutic monitoring, CNS Drugs, vol.23, issue.4, pp.331-349, 2009.

C. Couffignal, L. Chevillard, S. E. Balkhi, S. Cisternino, and X. Declèves, The pharmacokinetics of lithium, The science and practice of lithium therapy, 2017.

, , pp.25-53

M. A. Frye, T. A. Kimbrell, R. T. Dunn, S. Piscitelli, D. Grothe et al., Gabapentin does not alter single-dose lithium pharmacokinetics, J Clin Psychopharmacol, vol.18, issue.6, pp.461-464, 1998.

C. F. Lee, Y. Y. Yang, and O. Y. Hu, Single dose pharmacokinetic study of lithium in Taiwanese/Chinese bipolar patients, Aust N Z J Psychiatry, vol.32, issue.1, pp.133-136, 1998.

D. P. Thornhill, Pharmacokinetics of ordinary and sustainedrelease lithium carbonate in manic patients after acute dosage, Eur J Clin Pharmacol, vol.14, issue.4, pp.267-271, 1978.

M. E. Ward, M. N. Musa, and L. Bailey, Clinical pharmacokinetics of lithium, J Clin Pharmacol, vol.34, issue.4, pp.280-285, 1994.

N. Taright, F. Mentré, A. Mallet, and R. Jouvent, Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data: individualization of chronic dosing regimen using a new Bayesian approach, Ther Drug Monit, vol.16, issue.3, pp.258-269, 1994.

N. Valecha, G. Tayal, and K. D. Tripathi, Single dose pharmacokinetics of lithium & prediction of maintenance dose in manic depressive patients, Indian J Med Res, vol.92, pp.409-416, 1990.

Y. Y. Yang, E. K. Yeh, S. S. Chang, H. C. Deng, and C. F. Lee, Maintenance lithium levels could be lowered: based on Taiwanese and Danish studies, J Formos Med Assoc, vol.90, issue.5, pp.509-513, 1991.

E. Yukawa, N. Nomiyama, S. Higuchi, and T. Aoyama, Lithium population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens, Ther Drug Monit, vol.15, issue.2, pp.75-82, 1993.

J. Methaneethorn, Population pharmacokinetic analyses of lithium: a systematic review, Eur J Drug Metab Pharmacokinet, vol.43, issue.1, pp.25-34, 2018.

E. S. Eldesoky, V. Kumar, M. S. Alorainy, M. M. Hamdi, and H. Derendorf, Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach, Int J Clin Pharmacol Ther, vol.46, issue.12, pp.617-626, 2008.

L. Hoegberg, G. Jürgens, V. W. Zederkof, B. Holgersson, J. E. Andersson et al., A computerised sampling strategy for therapeutic drug monitoring of lithium provides precise estimates and significantly reduces dose-finding time, Basic Clin Pharmacol Toxicol, vol.110, issue.3, pp.259-263, 2012.

G. Ferron, M. Debray, F. Buneaux, F. J. Baud, and J. M. Scherrmann, Pharmacokinetics of lithium in plasma and red blood cells in acute and chronic intoxicated patients, Int J Clin Pharmacol Ther, vol.33, issue.6, pp.351-355, 1995.

J. Rybakowski, W. Lehmann, and R. Kanarkowski, Erythrocyte lithium-sodium countertransport and total body lithium pharmacokinetics in patients with affective illness, Hum Psychopharmacol Clin Exp, vol.3, issue.2, pp.87-93, 1988.

C. R. Lee, S. E. Hill, M. Dimitrakoudi, F. A. Jenner, and R. J. Pollitt, The relationship of plasma to erythrocyte lithium levels in patients taking lithium carbonate, Br J Psychiatry, vol.127, pp.596-598, 1975.

K. White, J. Cohen, J. Boyd, and R. Nelson, Relationship between plasma, RBC, and CSF lithium concentrations in human subjects, Int Pharmacopsychiatry, vol.14, issue.4, pp.185-189, 1979.

H. C. Schreiner, D. L. Dunner, H. L. Meltzer, and R. R. Fieve, The relationship of the lithium erythrocyte: plasma ratio to plasma lithium level, Biol Psychiatry, vol.14, issue.1, pp.207-213, 1979.

B. Vrijens and E. Goetghebeur, The impact of compliance in pharmacokinetic studies, Stat Methods Med Res, vol.8, issue.3, pp.247-262, 1999.

C. Boudebesse, P. A. Geoffroy, F. Bellivier, C. Henry, S. Folkard et al., Correlations between objective and subjective sleep and circadian markers in remitted patients with bipolar disorder, Chronobiol Int, vol.31, issue.5, pp.698-704, 2014.

P. Grof, A. Duffy, P. Cavazzoni, E. Grof, J. Garnham et al., Is response to prophylactic lithium a familial trait?, J Clin Psychiatry, vol.63, issue.10, pp.942-947, 2002.

E. Kuhn and M. Lavielle, Maximum likelihood estimation in nonlinear mixed effects models, Comput Stat Data Anal, vol.49, issue.4, pp.1020-1038, 2005.

K. Yoshida, H. Uchida, T. Suzuki, M. Watanabe, N. Yoshino et al., Prediction model of serum lithium concentrations, Pharmacopsychiatry, vol.51, issue.3, pp.82-88, 2018.

M. Valle, M. J. Barbanoj, A. Donner, I. Izquierdo, U. Herranz et al., Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers, Eur J Clin Pharmacol, vol.61, issue.2, pp.103-111, 2005.

T. Nguyen, M. Mouksassi, N. Holford, N. Al-huniti, I. Freedman et al., Model evaluation of continuous data pharmacometric models: metrics and graphics, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01484967

R. M. Savic and M. O. Karlsson, Importance of shrinkage in empirical Bayes estimates for diagnostics: problems and solutions, AAPS J, vol.11, issue.3, pp.558-569, 2009.

A. Dosne, R. Niebecker, and M. O. Karlsson, dOFV distributions: a new diagnostic for the adequacy of parameter uncertainty in nonlinear mixed-effects models applied to the bootstrap, J Pharmacokinet Pharmacodyn, vol.43, issue.6, pp.597-608, 2016.

R. Hunter, Steady-state pharmacokinetics of lithium carbonate in healthy subjects, Br J Clin Pharmacol, vol.25, issue.3, pp.375-380, 1988.

G. Johnson and G. E. Hunt, Pharmacokinetics of lithium preparations in patients, Prog Neuro-Psychopharmacol Biol Psychiatry, vol.8, issue.1, pp.63-70, 1984.

M. Camus, G. Henneré, G. Baron, G. Peytavin, L. Massias et al., Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acuteon-chronic toxicity, Eur J Clin Pharmacol, vol.59, issue.8-9, pp.583-587, 2003.

A. C. Swann, N. Berman, A. Frazer, S. H. Koslow, J. W. Maas et al., Lithium distribution in mania: single-dose pharmacokinetics and sympathoadrenal function, Psychiatry Res, vol.32, issue.1, pp.71-84, 1990.

A. J. Wood, J. K. Aronson, C. Bunch, and G. Dg, A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole, Br J Clin Pharmacol, vol.27, issue.6, pp.749-756, 1989.

B. J. Lauritsen, E. T. Mellerup, P. Plenge, S. Rasmussen, P. Vestergaard et al., Serum lithium concentrations around the clock with different treatment regimens and the diurnal variation of the renal lithium clearance, Acta Psychiatr Scand, vol.64, issue.4, pp.314-319, 1981.

J. E. Murphy, D. Ljubicic, M. Letica-crepulja, D. Vitezic, I. L. Bistrovic et al., Lithium treatments: single and multiple daily dosing, Clinical pharmacokinetics. ASHP, 433 p 48, vol.53, pp.323-331, 2008.

D. Tomalik-scharte, A. A. Suleiman, S. Frechen, D. Kraus, U. Kerkweg et al., Population pharmacokinetic analysis of circadian rhythms in hepatic CYP3A activity using midazolam, J Clin Pharmacol, vol.54, issue.10, pp.1162-1169, 2014.

A. Bienczak, A. Cook, L. Wiesner, V. Mulenga, C. Kityo et al., Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children, J Antimicrob Chemother, vol.72, issue.1, pp.190-199, 2017.

L. Kervezee, J. Stevens, W. Birkhoff, I. Kamerling, T. De-boer et al., Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach, Br J Clin Pharmacol, vol.81, issue.2, pp.256-268, 2016.